APO RESEARCH · REPORT
Vaccine
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).
Product & engineering
Understand the product.
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).
Selected research
Industry Growth & Trends
Global Vaccine Industry Growth and Trends Forecast to 2032
Market perspective
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).
According to APO Research, the global Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
Read the full market overview
The Europe market for Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
The Asia Pacific market for Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Vaccine market include AstraZeneca, BioNTech, Boehringer-Ingelheim, CCBIO, CSL, CureVac, Elanco, GSK and Hulan Bio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Vaccine market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Vaccine.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Vaccine Market by Company
AstraZeneca
BioNTech
Boehringer-Ingelheim
CCBIO
CSL
CureVac
Elanco
GSK
Hulan Bio
Indian Immunologicals
Merck
Minhai Biotechnology
Mitsubishi Tanabe Pharma
Moderna Therapeutics
Mylan
Plumbline Life Sciences
Sanofi
Translate Bio
Walvax Biotechnology
Wuhan Institute of Biological Products
Zoties
Vaccine Segment by Type
Varicella Vaccine
Influenza Vaccine
Polio Vaccine
Hepatitis A Vaccine
Rabies Vaccine
BCG Vaccine
Hepatitis B
Pertussis, Diphtheria, Tetanus
Pneumococcal
Others
Vaccine Segment by Application
For Adult
For Child
Vaccine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Vaccine companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Varicella Vaccine
- Influenza Vaccine
- Polio Vaccine
- Hepatitis A Vaccine
- Rabies Vaccine
- BCG Vaccine
- Hepatitis B
- Pertussis, Diphtheria, Tetanus
- Pneumococcal
- Others
Applications
- For Adult
- For Child
Companies covered
- AstraZeneca
- BioNTech
- Boehringer-Ingelheim
- CCBIO
- CSL
- CureVac
- Elanco
- GSK
- Hulan Bio
- Indian Immunologicals
- Merck
- Minhai Biotechnology
- Mitsubishi Tanabe Pharma
- Moderna Therapeutics
- Mylan
- Plumbline Life Sciences
- Sanofi
- Translate Bio
- Walvax Biotechnology
- Wuhan Institute of Biological Products
- Zoties
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Vaccine Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Vaccine Market Size by Region (2021-2032)
- 1.4.1 Global Vaccine Market Size by Region (2021-2026)
- 1.4.2 Global Vaccine Market Size by Region (2027-2032)
- 1.5 Key Regions Vaccine Market Size (2021-2032)
- 1.5.1 North America Vaccine Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Vaccine Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Vaccine Market Size Growth Rate (2021-2032)
- 1.5.4 South America Vaccine Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Vaccine Market Size Growth Rate (2021-2032)
2 Vaccine Market by Type
- 2.1 Type Introduction
- 2.1.1 Varicella Vaccine
- 2.1.2 Influenza Vaccine
- 2.1.3 Polio Vaccine
- 2.1.4 Hepatitis A Vaccine
- 2.1.5 Rabies Vaccine
- 2.1.6 BCG Vaccine
- 2.1.7 Hepatitis B
- 2.1.8 Pertussis, Diphtheria, Tetanus
- 2.1.9 Pneumococcal
- 2.1.10 Others
- 2.2 Global Vaccine Market Size by Type
- 2.2.1 Global Vaccine Market Size Overview by Type (2021-2032)
- 2.2.2 Global Vaccine Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Vaccine Market Size Forecasted by Type (2027-2032)
- 2.3 Global Vaccine Market Size by Regions
- 2.3.1 North America Vaccine Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Vaccine Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Vaccine Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Vaccine Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Vaccine Market Size Breakdown by Type (2021-2026)
3 Vaccine Market by Application
- 3.1 Type Introduction
- 3.1.1 For Adult
- 3.1.2 For Child
- 3.2 Global Vaccine Market Size by Application
- 3.2.1 Global Vaccine Market Size Overview by Application (2021-2032)
- 3.2.2 Global Vaccine Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Vaccine Market Size Forecasted by Application (2027-2032)
- 3.3 Global Vaccine Market Size by Regions
- 3.3.1 North America Vaccine Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Vaccine Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Vaccine Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Vaccine Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Vaccine Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Vaccine Industry Trends
- 4.2 Vaccine Industry Drivers
- 4.3 Vaccine Industry Opportunities and Challenges
- 4.4 Vaccine Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Vaccine Revenue (2021-2026)
- 5.2 Global Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Vaccine Key Company Headquarters & Area Served
- 5.4 Global Vaccine Company, Product Type & Application
- 5.5 Global Vaccine Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Vaccine Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Vaccine Players Market Share by Revenue in 2025
- 5.6.3 2025 Vaccine Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 AstraZeneca
- 6.1.1 AstraZeneca Company Information
- 6.1.2 AstraZeneca Business Overview
- 6.1.3 AstraZeneca Vaccine Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 AstraZeneca Vaccine Product Portfolio
- 6.1.5 AstraZeneca Recent Developments
- 6.2 BioNTech
- 6.2.1 BioNTech Company Information
- 6.2.2 BioNTech Business Overview
- 6.2.3 BioNTech Vaccine Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 BioNTech Vaccine Product Portfolio
- 6.2.5 BioNTech Recent Developments
- 6.3 Boehringer-Ingelheim
- 6.3.1 Boehringer-Ingelheim Company Information
- 6.3.2 Boehringer-Ingelheim Business Overview
- 6.3.3 Boehringer-Ingelheim Vaccine Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Boehringer-Ingelheim Vaccine Product Portfolio
- 6.3.5 Boehringer-Ingelheim Recent Developments
- 6.4 CCBIO
- 6.4.1 CCBIO Company Information
- 6.4.2 CCBIO Business Overview
- 6.4.3 CCBIO Vaccine Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 CCBIO Vaccine Product Portfolio
- 6.4.5 CCBIO Recent Developments
- 6.5 CSL
- 6.5.1 CSL Company Information
- 6.5.2 CSL Business Overview
- 6.5.3 CSL Vaccine Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 CSL Vaccine Product Portfolio
- 6.5.5 CSL Recent Developments
- 6.6 CureVac
- 6.6.1 CureVac Company Information
- 6.6.2 CureVac Business Overview
- 6.6.3 CureVac Vaccine Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 CureVac Vaccine Product Portfolio
- 6.6.5 CureVac Recent Developments
- 6.7 Elanco
- 6.7.1 Elanco Company Information
- 6.7.2 Elanco Business Overview
- 6.7.3 Elanco Vaccine Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Elanco Vaccine Product Portfolio
- 6.7.5 Elanco Recent Developments
- 6.8 GSK
- 6.8.1 GSK Company Information
- 6.8.2 GSK Business Overview
- 6.8.3 GSK Vaccine Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 GSK Vaccine Product Portfolio
- 6.8.5 GSK Recent Developments
- 6.9 Hulan Bio
- 6.9.1 Hulan Bio Company Information
- 6.9.2 Hulan Bio Business Overview
- 6.9.3 Hulan Bio Vaccine Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Hulan Bio Vaccine Product Portfolio
- 6.9.5 Hulan Bio Recent Developments
- 6.10 Indian Immunologicals
- 6.10.1 Indian Immunologicals Company Information
- 6.10.2 Indian Immunologicals Business Overview
- 6.10.3 Indian Immunologicals Vaccine Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Indian Immunologicals Vaccine Product Portfolio
- 6.10.5 Indian Immunologicals Recent Developments
- 6.11 Merck
- 6.11.1 Merck Company Information
- 6.11.2 Merck Business Overview
- 6.11.3 Merck Vaccine Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Merck Vaccine Product Portfolio
- 6.11.5 Merck Recent Developments
- 6.12 Minhai Biotechnology
- 6.12.1 Minhai Biotechnology Company Information
- 6.12.2 Minhai Biotechnology Business Overview
- 6.12.3 Minhai Biotechnology Vaccine Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Minhai Biotechnology Vaccine Product Portfolio
- 6.12.5 Minhai Biotechnology Recent Developments
- 6.13 Mitsubishi Tanabe Pharma
- 6.13.1 Mitsubishi Tanabe Pharma Company Information
- 6.13.2 Mitsubishi Tanabe Pharma Business Overview
- 6.13.3 Mitsubishi Tanabe Pharma Vaccine Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Mitsubishi Tanabe Pharma Vaccine Product Portfolio
- 6.13.5 Mitsubishi Tanabe Pharma Recent Developments
- 6.14 Moderna Therapeutics
- 6.14.1 Moderna Therapeutics Company Information
- 6.14.2 Moderna Therapeutics Business Overview
- 6.14.3 Moderna Therapeutics Vaccine Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Moderna Therapeutics Vaccine Product Portfolio
- 6.14.5 Moderna Therapeutics Recent Developments
- 6.15 Mylan
- 6.15.1 Mylan Company Information
- 6.15.2 Mylan Business Overview
- 6.15.3 Mylan Vaccine Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Mylan Vaccine Product Portfolio
- 6.15.5 Mylan Recent Developments
- 6.16 Plumbline Life Sciences
- 6.16.1 Plumbline Life Sciences Company Information
- 6.16.2 Plumbline Life Sciences Business Overview
- 6.16.3 Plumbline Life Sciences Vaccine Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Plumbline Life Sciences Vaccine Product Portfolio
- 6.16.5 Plumbline Life Sciences Recent Developments
- 6.17 Sanofi
- 6.17.1 Sanofi Company Information
- 6.17.2 Sanofi Business Overview
- 6.17.3 Sanofi Vaccine Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Sanofi Vaccine Product Portfolio
- 6.17.5 Sanofi Recent Developments
- 6.18 Translate Bio
- 6.18.1 Translate Bio Company Information
- 6.18.2 Translate Bio Business Overview
- 6.18.3 Translate Bio Vaccine Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Translate Bio Vaccine Product Portfolio
- 6.18.5 Translate Bio Recent Developments
- 6.19 Walvax Biotechnology
- 6.19.1 Walvax Biotechnology Company Information
- 6.19.2 Walvax Biotechnology Business Overview
- 6.19.3 Walvax Biotechnology Vaccine Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 Walvax Biotechnology Vaccine Product Portfolio
- 6.19.5 Walvax Biotechnology Recent Developments
- 6.20 Wuhan Institute of Biological Products
- 6.20.1 Wuhan Institute of Biological Products Company Information
- 6.20.2 Wuhan Institute of Biological Products Business Overview
- 6.20.3 Wuhan Institute of Biological Products Vaccine Revenue, Global Share and Gross Margin (2021-2026)
- 6.20.4 Wuhan Institute of Biological Products Vaccine Product Portfolio
- 6.20.5 Wuhan Institute of Biological Products Recent Developments
- 6.21 Zoties
- 6.21.1 Zoties Company Information
- 6.21.2 Zoties Business Overview
- 6.21.3 Zoties Vaccine Revenue, Global Share and Gross Margin (2021-2026)
- 6.21.4 Zoties Vaccine Product Portfolio
- 6.21.5 Zoties Recent Developments
7 North America
- 7.1 North America Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Vaccine Market Size by Country (2021-2026)
- 7.3 North America Vaccine Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Vaccine Market Size by Country (2021-2026)
- 8.3 Europe Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Vaccine Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Vaccine Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Vaccine Market Size by Country (2021-2026)
- 10.3 South America Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Vaccine Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Vaccine Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst